DNA polymerase mu
DNA polymerase mu (Pol μ) is a unique DNA polymerase that is involved in the process of non-homologous end joining (NHEJ), a mechanism used by cells to repair double-strand breaks in DNA. Unlike most DNA polymerases, Pol μ possesses the ability to perform template-independent DNA synthesis, making it crucial for the repair of breaks that have incompatible or damaged ends. This enzyme is a member of the X family of DNA polymerases, which also includes Pol β, Pol λ, and TdT.
Function[edit | edit source]
Pol μ's primary role is in the repair of double-strand breaks in DNA through NHEJ. This pathway is essential for maintaining genomic stability, especially in the immune system during V(D)J recombination, a process that generates the diversity of antibodies. Unlike homologous recombination, NHEJ does not require a homologous template, making Pol μ's template-independent activity particularly valuable. Pol μ can add nucleotides at the break site, facilitating the bridging and eventual ligation of the DNA ends.
Structure[edit | edit source]
The structure of Pol μ shares similarities with other members of the X family of DNA polymerases, including a BRCT domain that is thought to be involved in protein-protein interactions necessary for its function in DNA repair. However, Pol μ also exhibits unique structural features that enable its template-independent synthesis capabilities, including a highly flexible active site.
Clinical Significance[edit | edit source]
Mutations in the gene encoding Pol μ have been associated with an increased susceptibility to various cancers, highlighting the enzyme's role in preventing genomic instability. Additionally, due to its role in V(D)J recombination, alterations in Pol μ activity can impact the immune system's ability to generate antibody diversity, potentially leading to immunodeficiency disorders.
Research[edit | edit source]
Research on Pol μ is ongoing, with studies aimed at elucidating its precise mechanisms of action, its interactions with other proteins involved in DNA repair, and its potential as a target for cancer therapy. Understanding the detailed function of Pol μ could lead to novel approaches to enhance DNA repair in diseases characterized by genomic instability.
See Also[edit | edit source]
References[edit | edit source]
Y-STR Name |
Haplotype |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD